Bio Impact Capital LLC Guardant Health, Inc. Transaction History
Bio Impact Capital LLC
- $540 Million
- Q1 2025
A detailed history of Bio Impact Capital LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 442,656 shares of GH stock, worth $22.5 Million. This represents 3.49% of its overall portfolio holdings.
Number of Shares
442,656
Previous 452,739
2.23%
Holding current value
$22.5 Million
Previous $13.8 Million
36.34%
% of portfolio
3.49%
Previous 2.07%
Shares
4 transactions
Others Institutions Holding GH
# of Institutions
393Shares Held
121MCall Options Held
1.43MPut Options Held
2.37M-
Vanguard Group Inc Valley Forge, PA12.1MShares$614 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$572 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$277 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$262 Million0.04% of portfolio
-
Baillie Gifford & CO5.06MShares$257 Million0.19% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.2B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...